Figure 2.

Network formed by interventions and their direct comparisons included in the analyses.

Note: The GLOW2 trial compares glycopyrronium to tiotropium 18 μg and placebo and is therefore included three times in this figure.

Abbreviations: GLOW, GLycopyrronium bromide in COPD airways clinical study; OD, once daily; BID, twice a day.